Search – Page 124 – Indianapolis Business Journal

Home » Search

Articles

SKARBECK: Indiana gets aggressive in touting advantages

June 25, 2015

Indiana’s latest pitch to lure business received national attention and stirred up some controversy. Yet that is exactly what a full-page ad in The Wall Street Journal is meant to do. So, mission accomplished.

Deep in ‘Cave,’ Lilly CEO decided Alzheimer’s drug’s fate

June 26, 2015

Eli Lilly and Co. is preparing to release data on its experimental Alzheimer’s disease treatment, solanezumab, after years of sometimes positive but often discouraging research.

Company news

June 26, 2015

Eli Lilly and Co. got good news and bad news about its top-selling drug, the lung cancer therapy Alimta. According to Bloomberg News, a British court upheld a patent protecting a vitamin regimen administered with the drug and said that patent would be infringed by a generic competitor. Lilly's patent protecting Alimta's chemical makeup expires […]

Developer soars with ‘special needs’ housing niche

July 1, 2015

Gary Hobbs and his wife, Lori, have built BWI LLC into a fast-growing developer of affordable housing with 48 employees and more than $10 million in annual revenue.

Resurgence of Eli Lilly is touching all corners of region

July 1, 2015

Central Indiana's economy is diverse, but Lilly is such a behemoth that its ups and downs reverberate statewide.

Brownsburg entrepreneur is a cryogenic-tooth-banking pioneer

July 1, 2015

Michael A. Byers’ Tooth Bank is one of a tiny group of U.S. companies catering to the latest iteration of stem cell therapy: harvesting stem cells from the pulp inside baby teeth and extracted wisdom teeth, then culturing, freezing and storing them at a cryostorage facility for later use.

Indiana’s medical research ‘trade deficit’

July 2, 2015

Indiana's life sciences companies are spending four times more on medical research than the state's hospitals, doctors and univerities are receiving from such companies for research projects. That means Indiana is missing out on more than $80 million a year.

Clot risk in Lilly lung-cancer drug raises FDA concerns

July 7, 2015

The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.

Lilly, partner sue Lupin over generic testosterone

July 8, 2015

Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.

PROXY CORNER: Eli Lilly and Co.

July 9, 2015

Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals.

$17M Marriott hotel in works near Lucas Oil Stadium

July 10, 2015

An Illinois-based developer has received the first approval necessary to build a 140-room extended-stay hotel downtown, as Indy’s lodging market continues to swell.

Company news

July 13, 2015

Twenty-six people have sued Anthem Inc. claiming identity theft and fraud due to the massive data breach Anthem reported on Feb. 4. The Indianapolis-based health insurer had 78.8 million current and former customers’ records stolen by hackers from Dec. 10 to Jan. 27. But Anthem maintains it’s not the source of its customers’ troubles because […]

FAST 25: The Etica Group Inc.

July 15, 2015

The Etica Group, which started 10 years ago as an architecture and engineering firm, has morphed into a company with four core areas: architecture design (renovation and rehab for higher education and industrial/pharmaceutical work); engineering design (sanitary sewer and storm water projects); a building envelope division (maintaining exteriors); and construction observation.

Openings: B Spot Burger, Repeal, Scotty’s latest creation

July 16, 2015

Ironworks at Keystone will boast a new-to-Indy burger joint this month, as a tea shop pours into the nearby Fashion Mall. In Fletcher Place, the new restaurant Repeal harkens back to 1933.

Lilly partner Immunocore raises record $320 million

July 16, 2015

Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.

Ambitious development plans start to take root near Lucas Oil Stadium

July 16, 2015

Emboldened by the proposed development of a Marriott hotel, and prospects for another new hotel, the group that promotes downtown’s south side is beginning to lay the groundwork to transform the largely ignored area into a destination.

Lilly faces moment of truth this week

July 20, 2015

The Indianapolis-based drugmaker on Wednesday will release new data from patients taking its Alzheimer’s drug that could show whether the drug has slowed the progression of their disease. That will show investors whether the 45 percent rise in Lilly’s stock price over the past year is justified.

« Previous 1 … 122 123 124 125 126 … 221 Next »

Search Results

4,414 results for '\"eli lilly\"'

Articles

SKARBECK: Indiana gets aggressive in touting advantages

Deep in ‘Cave,’ Lilly CEO decided Alzheimer’s drug’s fate

Company news

Developer soars with ‘special needs’ housing niche

Resurgence of Eli Lilly is touching all corners of region

Brownsburg entrepreneur is a cryogenic-tooth-banking pioneer

Indiana’s medical research ‘trade deficit’

Clot risk in Lilly lung-cancer drug raises FDA concerns

Lilly, partner sue Lupin over generic testosterone

PROXY CORNER: Eli Lilly and Co.

$17M Marriott hotel in works near Lucas Oil Stadium

Company news

FAST 25: The Etica Group Inc.

Openings: B Spot Burger, Repeal, Scotty’s latest creation

Lilly partner Immunocore raises record $320 million

Ambitious development plans start to take root near Lucas Oil Stadium

Lilly faces moment of truth this week

Study shows Lilly’s Alzheimer’s drug has small but lasting benefit

Lilly posts lackluster profit but boosts full-year forecast